Download a brochure (PDF) : Pharmaceutical Excipients Market
Update on request
Based on recent market study data, the total market for excipients is estimated at US.5 billion with an average annual growth of 7% to 8% in volume and 4% to 5% in value. North America and Europe, as the main pharmaceutical producing areas, consume approximately 70% of excipient output. Japan takes another estimated 15% and India, Brazil and China have become major single markets in recent years.
There are currently 1,200 or so excipients on the market and they fulfil the needs of the majority of finished pharmaceutical products. There is no unmet need in immediate-release dosage forms for new excipients, although the big exception here is for modified-release dosage forms.
In general, there is an increased recognition of the role of excipients in the drug delivery process coupled with an increased research on the impact of excipients to enhance the bioavailability of active ingredients.
The purpose of this proposed study is to provide a global view of the pharmaceutical excipient sector. It describes the market trends and growth prospects, the supply and level of competition, as well as possible new entrants. On the market, lactose is currently used for tablets, pre-compression, granulation, liquids, caps, and inhalation products.